Cargando…
Conundrum of Classifying Subtypes of Pulmonary Hypertension—Introducing a Novel Approach to Classify “Borderline” Patients in a Population with Severe Aortic Stenosis Undergoing TAVI
Background: Transcatheter aortic valve implantation (TAVI) is an established therapeutic option in patients with severe aortic valve stenosis (AS) and a high surgical risk profile. Pulmonary hypertension (PH)—often co-existing with severe AS—is associated with a limited factor for prognosis and surv...
Autores principales: | Boxhammer, Elke, Gharibeh, Sarah X., Wernly, Bernhard, Kelm, Malte, Franz, Marcus, Kretzschmar, Daniel, Hoppe, Uta C., Lauten, Alexander, Lichtenauer, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505198/ https://www.ncbi.nlm.nih.gov/pubmed/36135439 http://dx.doi.org/10.3390/jcdd9090294 |
Ejemplares similares
-
Comparison of PCWP and LVEDP Measurements in Patients with Severe Aortic Stenosis Undergoing TAVI—Same Same but Different?
por: Boxhammer, Elke, et al.
Publicado: (2022) -
Microparticles in patients undergoing transcatheter aortic valve implantation (TAVI)
por: Jung, Christian, et al.
Publicado: (2016) -
Biomarkers of Atrial Fibrillation Recurrence in Patients with Paroxysmal or Persistent Atrial Fibrillation Following External Direct Current Electrical Cardioversion
por: Demirel, Ozan, et al.
Publicado: (2023) -
Soluble ST2 as a Potential Biomarker for Risk Assessment of Pulmonary Hypertension in Patients Undergoing TAVR?
por: Boxhammer, Elke, et al.
Publicado: (2022) -
The Lactate/Albumin Ratio: A Valuable Tool for Risk Stratification in Septic Patients Admitted to ICU
por: Lichtenauer, Michael, et al.
Publicado: (2017)